Dr. Daniel Judge, a leading expert in cardiovascular genetics at the Medical University of South Carolina, shares his insights on transthyretin amyloid cardiomyopathy (ATTR-CM). The discussion highlights the importance of recognizing subtle symptoms like ventricular hypertrophy and carpal tunnel syndrome. Dr. Judge also dives into innovative treatments, including gene-silencing technologies and antibody-based therapies, emphasizing the rapid advancements in this field. His passion for early diagnosis and improving patient outcomes shines throughout the conversation.